CMS unveils new Medicaid drug payment model

Max Bayer / endpoints - CMS plans to launch a new drug payment model for state Medicaid programs, the first of potentially multiple pricing models under President Donald Trump's "most favored nation" push that the pharma industry has been closely ...

AI Summary: The Centers for Medicare and Medicaid Services has introduced a novel Medicaid drug payment model that employs a most-favored nation pricing strategy, aiming to rein in healthcare spending. This bold move signals a shift toward competitive pricing that, while promising cost efficiencies, also raises eyebrows over its unorthodox approach.

---

Warning: Undefined variable $thumbnail in /home3/thegood9/public_html/website_70aad9ea/cluster.php on line 61

Related Stories

---

Warning: Undefined variable $top_stories in /home3/thegood9/public_html/website_70aad9ea/cluster.php on line 128

AbbVie sues over Botox selection in Medicare price negotiations / 3 months

HHS drops 340B pilot following court rulings / 3 months

HHS scraps 340B rebate pilot following court rulls / 3 months

FTC settles insulin lawsuit forces Express Scripts policy changes / 3 months

Judge blocks 340B drug pricing pilot program implementation / 4 months

Optum Rx/Caremark and FTC edge toward settlement in insulin case / 2 months

Life-extending prostate cancer drug to be offered to thousands in England / 4 months